Home
Applications
Indications
Business
EpiSwitch™
Products
EpiSwitch™ Service
Investors
Investors Overview
Results and Presentations
Share Price Information
Regulatory News
Board & Governance
Key Corporate Documents
AIM Rule 26
Email Alerts
Investor Contacts
News
About Us
History
Board of Directors
Management Team
Scientific Advisory Panel
Values
Careers
oxfordbiodynamics
Oxford BioDynamics to expand strategic focus
Press Release
by oxfordbiodynamics
Appointment of Chairman for Oxford Biodynamics Plc
Press Release
by oxfordbiodynamics
Strategic partnership with Boca Biolistics
Press Release
by oxfordbiodynamics
Disease severity program for COVID-19 advances
Press Release
by oxfordbiodynamics
Interim results for six months ended 31 March 2020
PDF
Press Release
by oxfordbiodynamics
Industry expert Dr Peter Pack, appointed as Non-Executive Chairman, succeeding Stephen Diggle
Press Release
by oxfordbiodynamics
Oxford BioDynamics biomarker platform is selected to help identify COVID-19 patients at risk of severe disease and profile patients who will benefit from therapeutic treatment
Press Release
by oxfordbiodynamics
Board restructure to support future growth
Press Release
by oxfordbiodynamics
Oxford BioDynamics to present at BioTech Pharma Summit: Liquid Biopsy 2020 in Lisbon, Portugal
Press Release
by oxfordbiodynamics
Oxford Biodynamics Plc enters into master service agreement with world leading US pharmaceutical company to evaluate EpiSwitch™ biomarkers
Press Release
by oxfordbiodynamics
1
2
3
…
9
Privacy Preference Center
Privacy Preferences
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with this.
Ok
Read more
